Protagonist Therapeutics, Inc. (PTGX): Price and Financial Metrics
PTGX Price/Volume Stats
| Current price | $42.64 | 52-week high | $48.89 |
| Prev. close | $43.26 | 52-week low | $18.07 |
| Day low | $42.34 | Volume | 91,356 |
| Day high | $43.49 | Avg. volume | 745,099 |
| 50-day MA | $45.05 | Dividend yield | N/A |
| 200-day MA | $36.38 | Market Cap | 2.54B |
PTGX Stock Price Chart Interactive Chart >
Protagonist Therapeutics, Inc. (PTGX) Company Bio
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded in 2006 and is based in Milpitas, California.
PTGX Price Returns
| 1-mo | -8.81% |
| 3-mo | 2.01% |
| 6-mo | 25.34% |
| 1-year | 133.77% |
| 3-year | 32.14% |
| 5-year | 458.12% |
| YTD | 85.96% |
| 2023 | 110.17% |
| 2022 | -68.10% |
| 2021 | 69.64% |
| 2020 | 185.96% |
| 2019 | 4.75% |
Loading social stream, please wait...